Overall, coverage of both IPTp2+ and IPTp3+ has improved in recent years.
The World Health Organization (WHO)
Adherence to guidance on malaria case management in EVD-affected countries was low at the height of the EVD epidemic in Guinea, and there was substantial malaria diagnostic testing in the absence of adequate PPE, which could have contributed to increased EVD transmission in the healthcare setting.
The C580Y finding from outside of the greater Mekong subregion supports the consensus to upscale molecular surveillance of artemisinin resistance outside of South East Asia.
Uptake of malaria testing prior to treatment can be improved by increasing its awareness and addressing misunderstandings among caregivers, promoting testing practices among health workers, and availing caregivers living farther from health centres alternative opportunities for community case management of febrile illnesses.
Although I just did a Critique on the 2017 WHO Malaria Report, it is not the Report that needs to be fixed, it is the failing WHO Strategy.
The 2017 WHO report on the status of malaria at the end of 2016 is a mixture of good news and bad news, with the bad news predominating. Although Dr. Tedros, the Director General of WHO and Prof. Alonso, the Director of the Global Malaria Program are to be commended for their frank presentation of the negative trends, they need to identify the reasons for these trends if we are to make the changes needed to reverse them.
Thus I will attempt herein to analyze some of the reasons for these negative trends, and suggest changes needed if we are to overcome them.
This study has shown important factors that influence the uptake of malaria prevention methods during pregnancy in Senegal.
CHWs have the potential to play a major role in diagnosing and treating malaria, thereby decreasing under-five children mortality.
Community health workers and related cadres had important preventive, case management and promotive roles in malaria interventions.
From the perspective of health workers, use of intramuscular artesunate as pre-referral treatment of severe malaria cases at the health post is possible but dependent on training and availability of skilled workers.